Insulet International Ltd

Support type: Corporate Pump and Device Supporters
Level: Bronze

Insulet (NASDAQ: PODD), European headquarters based in London, is an innovative medical device company dedicated to making the lives of people with diabetes easier through the use of its Omnipod® product platform, an alternative to traditional insulin delivery methods. The Omnipod DASH™ Insulin Management System delivers all the benefits of discreet, intuitive and easy to use insulin management technology without the need to see or handle a needle. Founded in 2000, many users across the globe rely on Insulet's Omnipod® System to bring simplicity and freedom to their lives. For more information, please visit: www.myomnipod.com

Information for HCPs

COVID-19 Information for Healthcare Professionals